EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among black cisgender women in the Southern United States

Sylvia Shangani iD, Jaquetta M Reeves iD, Kristin Heron, Jessica M Sales, Kenneth K Mugwanya

PLOS One · 2025

DOI: 10.1371/journal.pone.0330698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Sylvia Shangani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Anti-HIV Agents, Black or African American, HIV Infections, Patient Acceptance of Health Care. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, Old Dominion University - College of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention may improve adherence for those with concerns with daily pills. Limited data exist on LAI-PrEP acceptability among Black women in the U.S., a population vulnerable to HIV. We assessed willingness to use LAI-PrEP among Black women eligible for PrEP in the Southern U.S.

Methods

We conducted a cross-sectional online survey of HIV-negative Black women from March to June 2022 in the U.S. South. Participants provided information on sociodemographic characteristics, HIV knowledge, PrEP awareness, and use, stigma, risk perception, medical mistrust, and healthcare access. Multivariate logistic regression models determined factors associated with willingness to use LAI-PrEP.

Results

Of 491 women, the mean (SD) age was 40.1 (17.5), 53% of participants had a college degree or lower, 79% were single, and 80% resided in urban/suburban settings. Thirty-nine percent were aware of PrEP before the study and 36.7% of women were willing to use LAI-PrEP. In multivariate analyses, PrEP awareness [adjusted odds ratio (aOR=2.37, 95% CI 1.40, 3.73, p < 0.001), having a personal clinician (aOR=2.01, 95% CI 1.10, 3.68, p = 0.02), HIV worried (aOR=1.78, 95% CI 1.09, 2.89, p = 0.02), and medical trust (aOR=1.41, 95% CI 1.03, 1.93, p = 0.04) were statistically associated with willingness to use LAI-PrEP. However, the healthcare stereotype (beliefs that healthcare is biased) had lower odds of using LAI-PrEP (aOR=0.94, 95% CI 0.89, 0.99, p = 0.04).

Conclusion

Black women at risk for HIV are more likely to consider injectable PrEP when they understand HIV risk factors, are aware of PrEP, have a clinician, and trust the medical care. Implementing client-centered care interventions could effectively address medical mistrust and enhance engagement in HIV prevention services among Black women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsBlack or African AmericanHIV InfectionsPatient Acceptance of Health CarePre-Exposure ProphylaxisAdultFemaleHumansMiddle AgedYoung AdultCross-Sectional StudiesHealth Knowledge, Attitudes, PracticeInjectionsUnited States

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts, United States of America.
  • Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, Connecticut, United States of America.
  • College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, Texas, United States of America.
  • Department of Psychology, Old Dominion University, Norfolk, Virginia, United States of America.
  • Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
  • Departments of Epidemiology and Global Health, University of Washington, School of Public Health, Seattle, Washington, United States of America.

ORCID-Profile: Sylvia Shangani, Jaquetta M Reeves

Förderung

  • NIMH NIH HHS
  • Old Dominion University - College of Sciences

Zitieren

APA

Shangani, S., Reeves, J. M., Heron, K., Sales, J. M., & Mugwanya, K. K. (2025). Willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among black cisgender women in the Southern United States. PLOS One. https://doi.org/10.1371/journal.pone.0330698

Vancouver

Shangani S, Reeves JM, Heron K, Sales JM, Mugwanya KK. Willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among black cisgender women in the Southern United States. PLOS One. 2025. doi:10.1371/journal.pone.0330698

BibTeX
@article{Shangani2025,
  author = {Shangani, Sylvia and Reeves, Jaquetta M and Heron, Kristin and Sales, Jessica M and Mugwanya, Kenneth K},
  title = {Willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among black cisgender women in the Southern United States},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0330698}
}
Kostenlos starten →